These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 16452548

  • 1. Cortisol correlates with metabolic disturbances in a population study of type 2 diabetic patients.
    Oltmanns KM, Dodt B, Schultes B, Raspe HH, Schweiger U, Born J, Fehm HL, Peters A.
    Eur J Endocrinol; 2006 Feb; 154(2):325-31. PubMed ID: 16452548
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of Salivary Glucose and Salivary Cortisol in Association with Periodontitis in People with Type II Diabetes: A Case-control Study.
    de Almeida FR, de Sousa AM, de Farias Barbosa E, Vajgel BCF, Cimões R.
    Curr Diabetes Rev; 2024 Feb; 20(8):70-76. PubMed ID: 38173216
    [Abstract] [Full Text] [Related]

  • 6. Depression, smoking, physical inactivity and season independently associated with midnight salivary cortisol in type 1 diabetes.
    Melin EO, Thunander M, Landin-Olsson M, Hillman M, Thulesius HO.
    BMC Endocr Disord; 2014 Sep 16; 14():75. PubMed ID: 25224993
    [Abstract] [Full Text] [Related]

  • 7. Sex-related differences in the association of salivary cortisol levels and type 2 diabetes. Findings from the cross-sectional population based KORA-age study.
    Johar H, Emeny RT, Bidlingmaier M, Kruse J, Ladwig KH.
    Psychoneuroendocrinology; 2016 Jul 16; 69():133-41. PubMed ID: 27088372
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Association of diurnal patterns in salivary cortisol with type 2 diabetes in the Whitehall II study.
    Hackett RA, Steptoe A, Kumari M.
    J Clin Endocrinol Metab; 2014 Dec 16; 99(12):4625-31. PubMed ID: 25215558
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Safety profile and metabolic effects of 14 days of treatment with DIO-902: results of a phase IIa multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in patients with type 2 diabetes mellitus.
    Schwartz SL, Rendell M, Ahmann AJ, Thomas A, Arauz-Pacheco CJ, Welles BR.
    Clin Ther; 2008 Jun 16; 30(6):1081-8. PubMed ID: 18640464
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cortisol, obesity, and the metabolic syndrome: a cross-sectional study of obese subjects and review of the literature.
    Abraham SB, Rubino D, Sinaii N, Ramsey S, Nieman LK.
    Obesity (Silver Spring); 2013 Jan 16; 21(1):E105-17. PubMed ID: 23505190
    [Abstract] [Full Text] [Related]

  • 20. Salivary but not blood cortisol excretion is associated with metabolic biomarkers in healthy young women.
    Konishi S, O'Connor KA.
    Am J Hum Biol; 2016 Jul 16; 28(4):539-44. PubMed ID: 26779782
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.